DELEC1
Deleted in esophageal cancer 1
Also known as: DEC1_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for DELEC1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
70 residues, UniProt reviewed canonical sequence.
>Q9P2X7|DELEC1
1 MTMNVLEAGK WKSIVPAPGE GLLAVLHMMV FTDALHRERS VKWQAGVCYN GGKDFAVSLA
61 RPKAAEGIADLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DELEC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Protein domainsUniProt · Pfam · InterPro
- Deleted in esophageal cancer 1
- Deleted in esophageal cancer 1 family
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DELEC1 as an antibody target. Whether an autoantibody or antibody against DELEC1 could matter depends on whether native DELEC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DELEC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DELEC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...